stoxline Quote Chart Rank Option Currency Glossary
  
(PODD)
  0 (0%)    09-27 12:59
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:50:37 PM
Short term     
Mid term     
Targets 6-month :  394.63 1-year :  412.88
Resists First :  337.87 Second :  353.5
Pivot price 334.01
Supports First :  312.58 Second :  260.07
MAs MA(5) :  326.29 MA(20) :  336.67
MA(100) :  312.31 MA(250) :  280.79
MACD MACD :  0.1 Signal :  3.5
%K %D K(14,3) :  24.7 D(3) :  32.8
RSI RSI(14): 40.9
52-week High :  353.5 Low :  225.36
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PODD ] has closed above bottom band by 7.5%. Bollinger Bands are 8.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 326.78 - 329.06 329.06 - 330.82
Low: 311.51 - 314.6 314.6 - 316.97
Close: 313.76 - 317.91 317.91 - 321.09
Company Description

Headline News

Sat, 27 Sep 2025
Insulet Corporation $PODD Shares Acquired by Congress Asset Management Co. - MarketBeat

Sat, 27 Sep 2025
Western Financial Corp CA Makes New $1.06 Million Investment in Insulet Corporation $PODD - MarketBeat

Sat, 27 Sep 2025
Public Employees Retirement System of Ohio Trims Position in Insulet Corporation $PODD - MarketBeat

Fri, 26 Sep 2025
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally? - TradingView

Fri, 26 Sep 2025
Novem Group Acquires New Holdings in Insulet Corporation $PODD - MarketBeat

Wed, 24 Sep 2025
Should You Reconsider Insulet After Recent FDA Clearance for Omnipod 5 in 2025? - simplywall.st

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 70 (M)
Shares Float 70 (M)
Held by Insiders 0.2 (%)
Held by Institutions 101.8 (%)
Shares Short 1,620 (K)
Shares Short P.Month 1,750 (K)
Stock Financials
EPS 3.27
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 20.78
Profit Margin 10 %
Operating Margin 18.6 %
Return on Assets (ttm) 7.7 %
Return on Equity (ttm) 19.1 %
Qtrly Rev. Growth 32.9 %
Gross Profit (p.s.) 23.58
Sales Per Share 33.52
EBITDA (p.s.) 6.82
Qtrly Earnings Growth -87.7 %
Operating Cash Flow 516 (M)
Levered Free Cash Flow 113 (M)
Stock Valuations
PE Ratio 96.95
PEG Ratio 0
Price to Book value 15.3
Price to Sales 9.48
Price to Cash Flow 43.36
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android